The subject expert committee of the Drugs Controller General of India will also consider today Bharat Biotech's application to conduct phase 2/3 clinical trials of vaccine on pregnant women.
from Top India News- News18.com https://ift.tt/3I0WmAn
Serum Institute Applies for Market Authorisation of Covishield, SEC to Review Today
0
November 24, 2021
